Aarti Pharmalabs Ltd

NSE: AARTIPHARM BSE: 543748

₹691.80

(5.06%)

Sun, 21 Jun 2026, 08:27 am

MTF 5xInvest in Aarti Pharmalabs Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)6266.26

PE Ratio33.63

Dividend0.61

Health Technology

Pharmaceuticals: Major

24.5K

Aarti Pharmalabs News

Aarti Pharma Labs Q4 Profit Falls to 611M Rupees YoY

Aarti Pharma Labs reports Q4 consolidated net profit of 611M Rupees vs 883M YoY. EBITDA declined to 1.1B Rupees; margin contracted to 19.42% from 25.39%.

25 May 2026

companies

AARTI PHARMALABS investor meeting on May 28

AARTI PHARMALABS LIMITED will meet investors and analysts on May 28, 2026, at the 360 ONE Capital Conference. The meeting will be held in physical mode.

20 May 2026

companies

Aarti Pharmalabs Q4 FY26 call

Aarti Pharmalabs Limited has scheduled an earnings conference call for May 26, 2026, to discuss its Q4 FY26 financial results. The meeting will be held at 4:00 PM IST.

20 May 2026

companies

Aarti Pharmalabs Board Meet Rescheduled to May 25, 2026

Aarti Pharmalabs postpones its Board meeting from May 18 to May 25, 2026, to consider Q4 and FY26 audited results and final dividend. Trading Window closed till May 27, 2026.

14 May 2026

companies

Aarti Pharmalabs Board Meet Set for May 18, 2026

Aarti Pharmalabs schedules Board meeting on May 18, 2026 to consider audited financial results for Q4 and FY26, and recommend final dividend, if any.

11 May 2026

companies

Showing 1–5 of 44

Rows per page:

Market Current News

Anubhav Plast IPO subscribed 1.2x

Anubhav Plast IPO subscribed 1.2x overall. QIB subscribed 1.01x, Retail 1.18x, and Non-Institutional Buyers saw strong demand.

19 Jun 2026

ipo

Jio Platforms to Offer 270 Million New Shares in IPO

Jio Platforms, a subsidiary of Reliance Industries, plans to offer 270 million new shares in an upcoming India IPO, marking a significant capital market development.

19 Jun 2026

ipo

QMS MEDICAL ALLIED S LTD

QMS Medical migrates to NSE Mainboard

QMS Medical Allied Services migrated 1.93 crore shares to NSE Mainboard. FY26 revenue stood at ₹172.9 crore with EBITDA of ₹25.9 crore.

18 Jun 2026

ipo

NSE files ₹30,000 crore DRHP

NSE filed a DRHP for a ₹30,000 crore Offer for Sale, set to be India's largest IPO. Shares will list on BSE.

18 Jun 2026

ipo

Dhanwel Hybrid Seeds IPO analysis

Dhanwel Hybrid Seeds IPO opens Jun 24, 2026, to raise ₹19.20 crore. Revenue grew 110% to ₹74.59 crore in FY26, but operating cash flows remain negative.

18 Jun 2026

ipo

Showing 1–5 of 93902

Rows per page: